These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11855794)

  • 21. Effect of human Apo AIV against lipid peroxidation of very low density lipoproteins.
    Ferretti G; Bacchetti T; Bicchiega V; Curatola G
    Chem Phys Lipids; 2002 Jan; 114(1):45-54. PubMed ID: 11841825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired high density lipoprotein antioxidant activity in healthy postmenopausal women.
    Zago V; Sanguinetti S; Brites F; Berg G; Verona J; Basilio F; Wikinski R; Schreier L
    Atherosclerosis; 2004 Nov; 177(1):203-10. PubMed ID: 15488885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations.
    Leviev I; Deakin S; James RW
    J Lipid Res; 2001 Apr; 42(4):528-35. PubMed ID: 11290824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation.
    Mackness MI; Arrol S; Mackness B; Durrington PN
    Lancet; 1997 Mar; 349(9055):851-2. PubMed ID: 9121268
    [No Abstract]   [Full Text] [Related]  

  • 25. A longitudinal analysis of alteration in lecithin-cholesterol acyltransferase and paraoxonase activities following laparoscopic cholecystectomy relative to other parameters of HDL function and the acute phase response.
    Kumon Y; Nakauchi Y; Kidawara K; Fukushima M; Kobayashi S; Ikeda Y; Suehiro T; Hashimoto K; Sipe JD
    Scand J Immunol; 1998 Oct; 48(4):419-24. PubMed ID: 9790313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of protection against oxidative modification of LDL by avian HDL.
    Mackness B; Durrington PN; Mackness MI
    Biochem Biophys Res Commun; 1998 Jun; 247(2):443-6. PubMed ID: 9642147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycation of high-density lipoprotein does not increase its susceptibility to oxidation or diminish its cholesterol efflux capacity.
    Rashduni DL; Rifici VA; Schneider SH; Khachadurian AK
    Metabolism; 1999 Feb; 48(2):139-43. PubMed ID: 10024072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical properties.
    Kontush A; de Faria EC; Chantepie S; Chapman MJ
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):526-33. PubMed ID: 14739123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cysteine substitutions in apolipoprotein A-I primary structure modulate paraoxonase activity.
    Oda MN; Bielicki JK; Berger T; Forte TM
    Biochemistry; 2001 Feb; 40(6):1710-8. PubMed ID: 11327831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein.
    Mackness MI; Arrol S; Durrington PN
    FEBS Lett; 1991 Jul; 286(1-2):152-4. PubMed ID: 1650712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of non-enzymatic glycation on aluminium-induced lipid peroxidation of human high density lipoproteins (HDL).
    Ferretti G; Bacchetti T; Marchionni C; Dousset N
    Nutr Metab Cardiovasc Dis; 2004 Dec; 14(6):358-65. PubMed ID: 15853120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein composition in NIDDM: effects of dietary oleic acid on the composition, oxidisability and function of low and high density lipoproteins.
    Dimitriadis E; Griffin M; Collins P; Johnson A; Owens D; Tomkin GH
    Diabetologia; 1996 Jun; 39(6):667-76. PubMed ID: 8781762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycation impairs high-density lipoprotein function.
    Hedrick CC; Thorpe SR; Fu MX; Harper CM; Yoo J; Kim SM; Wong H; Peters AL
    Diabetologia; 2000 Mar; 43(3):312-20. PubMed ID: 10768092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-density lipoprotein impedes glycation of low-density lipoprotein.
    Younis NN; Soran H; Charlton-Menys V; Sharma R; Hama S; Pemberton P; Elseweidy MM; Durrington PN
    Diab Vasc Dis Res; 2013 Mar; 10(2):152-60. PubMed ID: 22890407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A high density lipoprotein from Piaractus mesopotamicus, pacu, (Osteichthyes, Characidae), is associated with paraoxonase activity.
    Folly E; Bastos VL; Alves MV; Bastos JC; Atella GC
    Biochimie; 2001 Oct; 83(10):945-51. PubMed ID: 11728631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of insulin resistance on serum paraoxonase activity in a nondiabetic population.
    Yamada A; Shoji T; Tahara H; Emoto M; Nishizawa Y
    Metabolism; 2001 Jul; 50(7):805-11. PubMed ID: 11436186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients.
    Gugliucci A; Lunceford N; Kinugasa E; Ogata H; Schulze J; Kimura S
    Clin Chim Acta; 2007 Sep; 384(1-2):105-12. PubMed ID: 17632094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein.
    Graham A; Hassall DG; Rafique S; Owen JS
    Atherosclerosis; 1997 Dec; 135(2):193-204. PubMed ID: 9430369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myeloperoxidase-induced modification of HDL by isolevuglandins inhibits paraoxonase-1 activity.
    Aggarwal G; May-Zhang LS; Yermalitsky V; Dikalov S; Voynov MA; Amarnath V; Kon V; Linton MF; Vickers KC; Davies SS
    J Biol Chem; 2021 Sep; 297(3):101019. PubMed ID: 34331945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.